Centre for Commercialization of Regenerative Medicine-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Centre for Commercialization of Regenerative Medicine - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014247
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Centre for Commercialization of Regenerative Medicine (CCRM) is an healthcare service provider that offers cell reprogramming and engineering, cell manufacturing, bio materials and devices manufacturing. The center’s cell reprogramming and engineering offers various capabilities such as establishment of cell lines, cell banking of public, private, or specialty collections, mycoplasma testing, remote fail-safe storage and reagents and protocols. It also provides repair, regenerate or replace diseased cells, tissues and organs. The center collaborates with multinationals, small-medium enterprises and biotechnology companies, among others. CCRM is headquartered in Toronto, Ontario, Canada.

Centre for Commercialization of Regenerative Medicine – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Centre for Commercialization of Regenerative Medicine and Affigen Enter into Partnership 10
Hemostemix Enters into Co-Development Agreement with Commercialization of Regenerative Medicine 11
EMD Millipore Enters Into Co-Development Agreement With Centre for Commercialization of Regenerative Medicine 12
Centre for Commercialization of Regenerative Medicine – Key Competitors 13
Centre for Commercialization of Regenerative Medicine – Key Employees 14
Centre for Commercialization of Regenerative Medicine – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Other Significant Developments 16
Jan 13, 2016: GE Healthcare, FedDev Ontario commit CAD $40M for new CCRM-led centre to solve cell therapy manufacturing challenges 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Key Facts 2
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Centre for Commercialization of Regenerative Medicine, Deals By Therapy Area, 2011 to YTD 2017 8
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Centre for Commercialization of Regenerative Medicine and Affigen Enter into Partnership 10
Hemostemix Enters into Co-Development Agreement with Commercialization of Regenerative Medicine 11
EMD Millipore Enters Into Co-Development Agreement With Centre for Commercialization of Regenerative Medicine 12
Centre for Commercialization of Regenerative Medicine, Key Competitors 13
Centre for Commercialization of Regenerative Medicine, Key Employees 14

★海外企業調査レポート[Centre for Commercialization of Regenerative Medicine-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ubisoft Entertainment S.A.:企業の戦略・SWOT・財務分析
    Ubisoft Entertainment S.A. - Strategy, SWOT and Corporate Finance Report Summary Ubisoft Entertainment S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Orica Ltd:企業の戦略・SWOT・財務分析
    Orica Ltd - Strategy, SWOT and Corporate Finance Report Summary Orica Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Serum Institute of India Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Serum Institute of India Ltd (Serum Institute) is a biotechnology company that manufactures and markets vaccines and immuno-biologicals. The company offers products such as bacterial vaccines, viral vaccines, recombinant and combination vaccines, polysaccharide conjugate vaccines, meningococ …
  • Grupo Elektra, S.A. de C.V.:企業の戦略・SWOT・財務分析
    Grupo Elektra, S.A. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Grupo Elektra, S.A. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Carl Zeiss Meditec Inc.:医療機器:M&Aディール及び事業提携情報
    Summary Carl Zeiss Meditec Inc (Carl Zeiss Meditec), a subsidiary of Carl Zeiss Meditec AG is a medical technology company that manufactures and markets various healthcare products. The company provides ophthalmology and optometry products, neurosurgery products, ENT products, spine surgery products …
  • PCCW Limited:戦略・SWOT・企業財務分析
    PCCW Limited - Strategy, SWOT and Corporate Finance Report Summary PCCW Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Asuragen Inc:医療機器:M&Aディール及び事業提携情報
    Summary Asuragen Inc (Asuragen) is an oncology molecular diagnostic company that provides laboratory medicine solutions. The company offers products such as amplidex, quantidex, and custom reagents. It provides custom and companion diagnostic services, which include commercialization, product approv …
  • Schneider Electric SE:企業の戦略・SWOT・財務分析
    Schneider Electric SE - Strategy, SWOT and Corporate Finance Report Summary Schneider Electric SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Telenor ASA:企業の戦略・SWOT・財務分析
    Telenor ASA - Strategy, SWOT and Corporate Finance Report Summary Telenor ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Cancer Genetics Inc (CGIX):企業の財務・戦略的SWOT分析
    Summary Cancer Genetics Inc (CGI) is a pharmaceutical company that offers diagnostic products and services enabling precision medicine in the field of oncology. It offers products such as CGH microarrays, next-generation sequencing and DNA-FISH Probes. The company's oncology tests and laboratory ser …
  • MITIE Group plc (MTO):企業の財務・戦略的SWOT分析
    MITIE Group plc (MTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sihayo Gold Ltd:企業の戦略・SWOT・財務情報
    Sihayo Gold Ltd - Strategy, SWOT and Corporate Finance Report Summary Sihayo Gold Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Enterome Bioscience SA:医療機器:M&Aディール及び事業提携情報
    Summary Enterome Bioscience SA (Enterome) is a drug development company which develops medical tests, and companion diagnostics to develop the management of microbiome-related diseases. The company develops medical tests based on its metagenotype technology platform that helps to identify microbiome …
  • Medigen Biotechnology Corp (3176)-医療機器分野:企業M&A・提携分析
    Summary Medigen Biotechnology Corp (MBC) is a pharmaceutical company that carries out the research and development of biopharmaceuticals for the treatment of liver diseases and cancers. It focuses at developing new therapeutics, principally in the area of cancer and liver diseases. The company’s pro …
  • KPJ Healthcare Berhad (KPJ):企業の財務・戦略的SWOT分析
    Summary KPJ Healthcare Berhad (KPJ) is a healthcare service provider that offers medical services. The center offers services in the areas of anaesthesiology, cardiology and cardiothoracic surgery, child psychiatry, clinic pathology, occupational health services, orthopaedic and trauma surgery, diet …
  • Sun Resources NL (SUR):企業の財務・戦略的SWOT分析
    Summary Sun Resources NL (Sun Resources) is an oil and gas exploration and development company. The company explores and develops crude oil and natural gas. Its services include exploration, production, and development of unconventional oil and gas resources. Its projects include Delta Oil Project, …
  • American Airlines Group Inc (AAL):企業の財務・戦略的SWOT分析
    American Airlines Group Inc (AAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Suncor Energy Inc.:企業の戦略・SWOT・財務情報
    Suncor Energy Inc. - Strategy, SWOT and Corporate Finance Report Summary Suncor Energy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Baker IDI Heart and Diabetes Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Baker IDI Heart and Diabetes Institute (Baker Institute) is a medical research organization that offers diagnosis, prevention, treatment of diabetics and cardiovascular disease. The organization offers clinical services such as diabetes services, weight assessment and management clinic healt …
  • Viskase Companies Inc (VKSC):企業の財務・戦略的SWOT分析
    Viskase Companies Inc (VKSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆